PEDEvidence
Latest studiesAll common questions
GH & PEPTIDES · COMMON QUESTIONS

Can HGH cause insulin resistance, and does adding insulin fix the problem?

A lower glucose reading does not prove normal insulin sensitivity.

Evidence at a glanceGH-axis therapies can worsen glucose tolerance; insulin adds hypoglycemia risk

Increasing GH-axis activity can worsen glucose tolerance in susceptible people. Tesamorelin’s label, for example, calls for glucose assessment and warns about glucose intolerance or diabetes. This does not mean every GH-related treatment produces the same change, but it is a reason to evaluate metabolic outcomes rather than only chasing IGF-1.[1]

Exogenous insulin can lower blood glucose without removing the process that made more insulin necessary. It is therefore not proof that insulin sensitivity has been restored. Insulin is a powerful glucose-lowering medicine, and serious hypoglycemia can occur when its action does not match physiological needs.[2]

The appropriate question is why glucose regulation changed and whether the GH exposure remains justified. Adding more drugs to preserve an exposure has its own consequences. Monitoring and clinical assessment are more informative than a bodybuilding ratio or the assumption that a normal fasting glucose makes an insulin-containing regimen safe.[1][2]

Sources & further reading

  1. DailyMed: tesamorelin, IGF-1 and glucose precautions
  2. Humalog prescribing information: hypoglycemia and insulin action

Updated September 24, 2026 · Evidence summaries for understanding research.

Q&A episodes behind this question

This question draws on the following public Q&A topics. The answer above is independently researched and does not quote or represent either creator’s advice.